Search

Author/Creator Suh, Cheolwon

31. Phase II study of R–CVP followed by rituximab maintenance therapy for patients with advanced marginal zone lymphoma: consortium for improving survival of lymphoma (CISL) study. Issue 1 (16th October 2019)

Authors:
Oh, Sung Yong; Kim, Won Seog; Kim, Jin Seok; Kim, Seok Jin; Yoon, Dok Hyun; Yang, Deok‐Hwan; Lee, Won Sik; Kim, Hyo Jung; Yhim, Ho‐Young; Jeong, Seong Hyun; Won, Jong Ho; Lee, Suee; Kong, Jee Hyun; Lim, Sung‐Nam; Ji, Jun Ho; Kwon, Kyung A.; Lee, Gyeong‐Won; Lee, Jae Hoon; Lee, Ho Sup; Shin, Ho‐Jin
Journal:
Cancer communications
Issue:
Volume 39:Issue 1(2019)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

32. Pneumocystis pneumonia versus rituximab-induced interstitial lung disease in lymphoma patients receiving rituximab-containing chemotherapy. (7th October 2016)

Authors:
Park, Se Yoon; Kim, Mi Young; Choi, Won Jin; Yoon, Dok Hyun; Lee, Sang-Oh; Choi, Sang-Ho; Kim, Yang Soo; Suh, Cheolwon; Woo, Jun Hee; Kim, Sung-Han
Journal:
Medical mycology
Issue:
Volume 55:Number 4(2017)
Page Start:
349
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

33. Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP‐164 study). Issue 4 (24th January 2020)

Authors:
Lee, Ho Sup; Kim, Kihyun; Kim, Seok Jin; Lee, Je‐Jung; Kim, Inho; Kim, Jin Seok; Eom, Hyeon‐Seok; Yoon, Dok Hyun; Suh, Cheolwon; Shin, Ho‐Jin; Mun, Yeung‐Chul; Kim, Min Kyoung; Lim, Sung‐Nam; Choi, Chul Won; Kang, Hye Jin; Yoon, Sung‐Soo; Min, Chang‐Ki
Journal:
American journal of hematology
Issue:
Volume 95:Issue 4(2020:Apr.)
Page Start:
413
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

34. Prognostic effect of Ki-67 expression in rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone-treated diffuse large B-cell lymphoma is limited to non-germinal center B-cell-like subtype in late-elderly patients. Issue 9 (2nd September 2015)

Authors:
Koh, Young Wha; Hwang, Hee Sang; Park, Chan-Sik; Yoon, Dok Hyun; Suh, Cheolwon; Huh, Jooryung
Journal:
Leukemia & lymphoma
Issue:
Volume 56:Issue 9(2015:Sep.)
Page Start:
2630
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

35. Prognostic impact of concordant and discordant cytomorphology of bone marrow involvement in patients with diffuse, large, B-cell lymphoma treated with R-CHOP. Issue 5 (21st April 2013)

Authors:
Shim, Hyoeun; Oh, Jae-Il; Park, Sang Hyuk; Jang, Seongsoo; Park, Chan-Jeoung; Huh, Jooryung; Suh, Cheolwon; Chi, Hyun-Sook
Journal:
Journal of clinical pathology
Issue:
Volume 66:Issue 5(2013)
Page Start:
420
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

37. Prognostic significance of metabolic tumor burden by positron emission tomography/computed tomography in patients with relapsed/refractory diffuse large B‐cell lymphoma. Issue 2 (4th February 2015)

Authors:
Tateishi, Ukihide; Tatsumi, Mitsuaki; Terauchi, Takashi; Ando, Kiyoshi; Niitsu, Nozomi; Kim, Won Seog; Suh, Cheolwon; Ogura, Michinori; Tobinai, Kensei
Journal:
Cancer science
Issue:
Volume 106:Issue 2(2015:Feb.)
Page Start:
186
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

38. Prognostic significance of serum β2-microglobulin levels in patients with peripheral T-cell lymphoma not otherwise specified. Issue 1 (2nd January 2022)

Authors:
Kim, Hyung-Don; Cho, Hyungwoo; Sohn, Byeong Seok; Park, Chan-Sik; Huh, Jooryung; Ryu, Jin Sook; Lee, Sang-Wook; Yoon, Sang Eun; Kim, Seok Jin; Ko, Young Hyeh; Kim, Won Seog; Suh, Cheolwon
Journal:
Leukemia & lymphoma
Issue:
Volume 63:Issue 1(2022)
Page Start:
124
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

39. Real‐world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis. Issue 3 (24th February 2021)

Authors:
Yi, Jun Ho; Kim, Seok Jin; Yoon, Dok Hyun; Suh, Cheolwon; Chang, Myung Hee; Yang, Deok Hwan; Jo, Jae‐Cheol; Hyun, Shin Young; Eom, Hyeon‐Seok; Lee, Jeong‐Ok; Kwon, Ji Hyun; Han, Sang Hoon; Lee, Seung‐Shin; Kwak, Jae‐Yong; Kim, Se Hyung; Kim, Dae Sik; Lee, Ji Hyun; Oh, Sung Yong; Ryoo, Hun Mo; Kim...
Journal:
Cancer communications
Issue:
Volume 41:Issue 3(2021)
Page Start:
275
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗